Drug Trial Radar · NCT06715085
PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.
Last checked: Nov 20, 2026Latest source record: Feb 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Jan 23, 2025
Primary completion
Feb 1, 2026
Study completion Feb 1, 2027
Sponsor
- Lead sponsor
- Biotechnology Institute IMASDIndustry
- Sponsor type
- Industry
- First posted
- Dec 4, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate the efficacy of PRGF in reducing pain and improving patients' quality of life. Researchers will compare an experimental drug (Plasma Rich in Growth Factors) to a control corticosteroid solution in saline solution.
Conditions
- Diseases [C] - Musculoskeletal Diseases [C05
Interventions
Plasma Rich in Growth Factors (PRGF)Drug
The PRGF application consists of three series of infiltrations in the intervertebral disc, epidural space and facets, with a frequency of two weeks.
Corticosteroid solution (Celestone Cronodose suspension for injection) in saline solution.Drug
The corticosteroid solution application consists of two series of infiltrations of solution of corticosteroid (Celestone Cronodose injectable suspension \[betamethasone\]) and saline solution in the epidural space and in the facets, with a periodicity of one month between them.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of PRGF in reducing pain and improving patients' quality of life.Time frame: 6 moths follow up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clínica Eduardo Anitua
Vitoria-Gasteiz, Alava, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.